Back

Efficacy and safety of upstream unfractionated heparin compared with downstream administration in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.

8 March 2024 (08:30 - 13:45)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes II: management ST-Elevation Myocardial Infarction (STEMI) ACVC Premium Access ESC Acute CardioVascular Care 2024 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Bernardo Lisboa Resende

Coimbra Hospital and University Center, Coimbra (Portugal)

5 More presentations in this session

Presentation thumbnail
Impact of intra-aortic balloon pump diastolic augmentation on survival in patients with cardiogenic shock
Doctor B. Senman (Durham, US)
Abstract Slides
Presentation thumbnail
Impact of the guidelines recommendations in the management of non-ST-segment elevation myocardial infarction according to gender. Analysis of 30-day mortality.
Ms A. Carrete (Badalona, ES)
Abstract Slides
Presentation thumbnail
Clinical predictors of late left ventricle recovery in tako-tsubo syndrome
Mrs M. Lopez Flores (Seville, ES)
Abstract Slides
Presentation thumbnail
Prognostic evaluation of ST-segment elevation acute myocardial infarction according to lung ultrasound in the acute phase
Doctor J. Carreras (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Drug-coated balloon versus drug-eluting stenting coronary angioplasty for ST-elevation myocardial infarction: a systematic review and meta-analysis of real-world studies
Doctor M. Ohn (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Acute coronary syndromes II: management

The Event

Event poster

ESC Acute CardioVascular Care 2024

8 March - 10 March 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources